Suppr超能文献

应用 2005 年卡普里尼评分系统于整形外科患者:一项质量改进计划。

Applying the 2005 Caprini Score to Plastic Surgery Patients: A Quality Improvement Project.

机构信息

From the Division of Plastic and Reconstructive Surgery.

Department of Surgery, Geisinger Medical Center, Danville.

出版信息

Ann Plast Surg. 2023 Jun 1;90(6S Suppl 5):S617-S621. doi: 10.1097/SAP.0000000000003484. Epub 2023 Feb 24.

Abstract

BACKGROUND

The Caprini score is a validated scale that calculates a patient's 30-day venous thromboembolism (VTE) risk based on their comorbidities. The American Society of Plastic Surgeons published VTE prophylaxis recommendations in 2011 based on the Caprini score, but these recommendations are vague and up to physician interpretation. The purpose of this study is to evaluate postoperative outcomes after the application of strict guidelines using the Caprini score with specific VTE chemoprophylaxis benchmarks on plastic surgery patients.

METHODS

A retrospective cohort analysis was performed on all plastic surgery patients who underwent surgery between July 2019 and July 2021. Patients between July 2019 and June 2020 were not subjected to any specific VTE prophylaxis protocol, while patients from July 2020 to July 2021 were subjected to the newly created VTE prophylaxis protocol. Every patient received a calculated Caprini score at their preoperative history and physical. The primary outcomes measured include hematoma, deep vein thrombosis (DVT) and pulmonary embolism (PE).

RESULTS

Four hundred forty-one patients with 541 procedures were included in this study, with 275 patients in the "before" group and 166 patients in the "after" group. A total of 78.6% of patients received chemoprophylaxis in the "before" group compared with 20% in the "after" group. There was no significant difference in postoperative complications between the two groups including PE or DVT ( P = 0.2684 and 0.2696, respectively), with a trend toward hematoma formation in the "before" group ( P = 0.1358). After the application of evidence-based VTE guidelines, the patients stayed fewer days in the hospital (0.4 vs 0.7 days, P = 0.0085) and were less likely to be readmitted (2.4% vs 6.5%, P = 0.0333). The average cost per patient in the "before" group was $9.11 with a total cost of $3022.90. The average cost per patient in the "after" group was $4.23 with a total cost of $867.94 ( P = 0.032).

CONCLUSIONS

Our strict application of the Caprini score significantly and safely limited the number of patients receiving postoperative VTE chemoprophylaxis and showed no significant difference in postoperative hematoma, DVT, or PE.

摘要

背景

Caprini 评分是一种经过验证的量表,可根据患者的合并症计算其 30 天静脉血栓栓塞(VTE)风险。美国整形外科学会于 2011 年根据 Caprini 评分发布了 VTE 预防建议,但这些建议较为模糊,需要医生进行解读。本研究的目的是评估应用 Caprini 评分并结合特定 VTE 化学预防基准对整形外科患者进行严格指导后的术后结果。

方法

对 2019 年 7 月至 2021 年 7 月期间接受手术的所有整形外科患者进行回顾性队列分析。2019 年 7 月至 2020 年 6 月期间的患者未接受任何特定的 VTE 预防方案,而 2020 年 7 月至 2021 年 7 月期间的患者则接受了新制定的 VTE 预防方案。每位患者在术前病史和体检时都会计算出 Caprini 评分。主要结局指标包括血肿、深静脉血栓形成(DVT)和肺栓塞(PE)。

结果

本研究共纳入 441 例患者,共 541 例手术,其中“前”组 275 例,“后”组 166 例。“前”组中接受化学预防的患者比例为 78.6%,而“后”组仅为 20%。两组患者的术后并发症(包括 PE 或 DVT)无显著差异(P = 0.2684 和 0.2696),但“前”组血肿形成的趋势更明显(P = 0.1358)。在应用基于证据的 VTE 指南后,患者的住院天数(0.4 天对 0.7 天,P = 0.0085)和再入院率(2.4%对 6.5%,P = 0.0333)均有所降低。“前”组患者的平均每位患者费用为 9.11 美元,总费用为 3022.90 美元。“后”组患者的平均每位患者费用为 4.23 美元,总费用为 867.94 美元(P = 0.032)。

结论

我们严格应用 Caprini 评分显著且安全地限制了接受术后 VTE 化学预防的患者数量,且术后血肿、DVT 或 PE 无显著差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验